Comments
Commented by Fabian Lorenz on December 14th, 2023 | 07:20 CET
Climate Conference and Nel disappoint. BASF and Saturn Oil + Gas shares recommended as Buy
The World Climate Conference has disappointed - at least for anyone who had hoped for a clear stance on the end of fossil fuels. Negotiations on the final declaration took place throughout the night in Dubai. The result is sobering. The farewell to fossil fuels is only vaguely described. It has become clear in recent weeks that fossil fuels are here to stay for the foreseeable future and that their lobby is strong. Instead of new impetus, shareholders of Nel ASA received further bad news. The hydrogen pioneer had to announce the cancellation of a major order. And that is not all. BASF, on the other hand, has a tailwind. The share has been upgraded from "Sell" to "Buy". Analysts see more than 200% upside potential for Saturn Oil & Gas. The high cash flow enables the oil producer to expand production and reduce debt.
Read
Commented by Juliane Zielonka on December 14th, 2023 | 07:00 CET
dynaCERT, Volkswagen, Mercedes-Benz - Renewable energies in focus, feasibility and speed are key
This year's international climate conference, "COP28", is coming to an end with a strong statement. For the first time, the participating nations have committed themselves in writing to developing their energy resources away from fossil fuels and towards renewable energies. Host country Dubai, under the patronage of Sultan Al Jaber, achieved consensus among all participating countries. According to the agreement, countries are called upon to contribute to a global transition rather than being directly forced to implement this change independently. A company like dynaCERT, which has been campaigning for years for a CO₂-reducing hybrid solution to power diesel trucks in the logistics sector, could be on the verge of a breakthrough. The Company has already raised CAD 2.0 million in gross proceeds from an ongoing private placement, which it will now use to expand its technology. Meanwhile, Volkswagen plans to hire around 3,000 engineers in China to keep pace in the EV market. Mercedes-Benz, meanwhile, is expanding its offering in Dubai with an unusual move to maximize profits...
Read
Commented by Stefan Feulner on December 13th, 2023 | 08:00 CET
Morphosys, Power Nickel, Nvidia - A pre-Christmas gift
The stock market year 2023 brought with it a lot of volatility and no let-up in both geopolitical and fiscal policy upheavals. Nevertheless, Germany's leading index, the DAX, broke through to a new all-time high, while the precious metal gold also shot up to its highest level ever. On Monday, shareholders of the biotech company Morphosys also experienced a pre-Christmas gift, with an impressive gain of 30% at the end of the trading day.
Read
Commented by André Will-Laudien on December 13th, 2023 | 07:45 CET
Uranium, lithium or gold? The climate conference tells us which way to go! BYD, Globex Mining, VW and Mercedes!
At the international climate conference in Dubai, several Arab countries sharply criticized and ultimately rejected the global move away from fossil fuels. The move by Western countries is an "aggressive attack", said Kuwaiti Oil Minister Saad Hamad Nasser al-Barrak yesterday, Tuesday. "I am astonished by this extraordinary insistence on depriving people and many countries of their basic source of energy. This approach is racist and colonialist," al-Barrak continued. This means that there will be no decision on a global phase-out of oil and gas with the OPEC states. Therefore, the current World Climate Conference is likely to be inconclusive or conclude with unilateral declarations from the EU. However, there is much to suggest that commodities that positively impact the global climate will remain on the import list of industrialized countries. Which shares should be considered in this mixed situation?
Read
Commented by Fabian Lorenz on December 13th, 2023 | 07:30 CET
Several 100% upside potential? BioNTech, Bayer, Cardiol Therapeutics and Evotec in analyst check
We take a look at analysts' opinions on biotech and pharmaceutical stocks. Jefferies recently renewed its "Buy" recommendation for Evotec with a target price of EUR 34. The latest partnerships confirm that the Company's unique business model is working. The situation at Bayer is quite different. While the CEO is announcing radical changes, analysts are slashing their price targets, in some cases significantly. In contrast, analysts believe that Cardiol Therapeutics could achieve several 100% gains. The cash register is full to bursting, and an exciting news flow can be expected in 2024. At BioNTech, only the cash position is currently convincing. However, this is not enough for a buy recommendation.
Read
Commented by Armin Schulz on December 13th, 2023 | 06:40 CET
Rock Tech Lithium, Klimat X Developments, Plug Power - Which GreenTechs have potential?
GreenTech companies have become increasingly important in recent years as they focus on developing and disseminating technologies that promote environmental protection. One example of this is lithium refinement, which is required for the production of batteries for electric vehicles. Another crucial topic is CO2 certificates, which companies can purchase to offset their emissions. Hydrogen technology is also becoming increasingly important, as it is seen as a clean alternative to fossil fuels. We have selected a candidate from each sector and are examining their potential.
Read
Commented by André Will-Laudien on December 12th, 2023 | 13:40 CET
Game Changer in Cancer - The Biotech Gold List for 2024! MorphoSys, Defence Therapeutics, BioNTech and Bayer
The International Agency for Research on Cancer estimates the number of cancer deaths worldwide for the year 2022 to be around 10 million. However, the number of new cancer cases in the same year amounted to around 20 million, and cancer is still considered incurable. Lung cancer remains the sad frontrunner, claiming the most lives worldwide. Colorectal and stomach cancer follow at a considerable distance. However, since the original launch of the "Cancer Moonshot" in 2016, the fight against this incurable disease in the US has made some progress in the realization of therapies. Recently, there has been an increase in success stories from many biotech companies, and investors' enthusiasm is palpable once again. Where are the Biotech game changers lurking for the 2024 investment year?
Read
Commented by Armin Schulz on December 12th, 2023 | 06:50 CET
BioNTech, Defence Therapeutics, Bayer - Golden times for the biotech and pharma industry?
With the arrival of winter, people are increasingly worried about illnesses such as coronavirus and influenza. The current wave of diseases and the new coronavirus variant are increasing the demand for medicines, which could positively impact the shares of pharmaceutical and biotech companies. Biotech's success in drug development for COVID-19 vaccines has allowed the industry to flourish over the past two years. But after the boom came the crash. However, the stock market always moves in cycles. The current challenges in the healthcare sector, such as the rising number of cancer cases, could, therefore, mean golden times for pharmaceutical and biotech companies, as they not only contribute to improving global health but also offer attractive returns for investors.
Read
Commented by André Will-Laudien on December 12th, 2023 | 06:40 CET
Climate conference and Venice turns green! Oil remains in demand; goodbye hydrogen? Nel ASA, Prospera Energy and Plug Power in Focus
Too little, too slow, too half-hearted! Climate activists in Italy have drawn attention to themselves with a spectacular campaign. The "Extinction Rebellion" group members painted the famous Grand Canal in Venice fluorescent green. Some activists abseiled from the Rialto Bridge over the central canal of the northern Italian lagoon city on Saturday afternoon and poured dye into the water. Their action was intended to protest against the "ridiculous progress" made at the COP28 World Climate Conference in Dubai. "We are tired, we have had enough of being taken for fools by our governments and knowing that our future is in danger while politicians do nothing," they said in a statement to the press. How do we tackle the energy issues of the future? A look at selected energy stocks paints a clear picture.
Read
Commented by Stefan Feulner on December 12th, 2023 | 06:30 CET
Hensoldt, Defense Metals, RWE - Important milestones
Following the recent year-end rally on the world's stock markets, the chances of further price gains are good. Even in the last month of an eventful stock market year, plenty of activity remains. The course is being set with regard to the strategic goals for a successful 2024 as a whole. In addition, even in mid-December, major capital measures must be finalized before the books are closed.
Read